Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanfei Zhisou compound (also known as Xuanfei Zhisou Heji) is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of cough, including post-infectious cough and cough associated with acute or chronic bronchitis. Its therapeutic actions are characterized in TCM as ventilating the lung (Xuanfei), resolving phlegm, and suppressing cough (Zhisou). The formulation is a complex mixture of several herbal extracts, typically including *Schizonepeta tenuifolia*, *Peucedanum praeruptorum*, *Platycodon grandiflorus*, *Aster tataricus*, *Tussilago farfara*, *Citrus reticulata*, and *Glycyrrhiza uralensis*. It is widely utilized in clinical practice in China and has been the subject of large-scale real-world safety and efficacy studies to evaluate its adverse drug reaction profile and clinical utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xuanfei zhisou compound.